StockData
Kardigan, Inc. logo

Kardigan, Inc. (KARD) stock

KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.32−0.87 (-6.60%)

Close on Nov 18, 2026Market cap $1.15BP/E –Yield –

Kardigan operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$64.82M–
Q2 FY2026Jun 30, 2026-$118.76M–
Q3 FY2025Sep 30, 2025-$59.07M–
Q2 FY2025Jun 30, 2025-$57.13M–

More Kardigan figures

See a number that looks wrong?